0

    540737

    SGRL

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Shree Ganesh Remedies Limited Share Price Today

    Investment Returns

    Over 1 Month 2.98% Over 3 Months 27.11% Over 6 Months 56.52% Over 1 Year 13.37%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Shree Ganesh Remedies Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 811.00
    • P/E Ratio (TTM) 47.27
    • Beta 0.48
    • Book Value / share 126.98
    • Return on equity 17.28%
    • EPS (TTM) 13.84
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 6.27
    info icon alternate text

    Shree Ganesh Remedies Limited Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 33.20
    Operating Expense 25.50
    Net Profit 6.27
    Net Profit Margin (%) 18.88
    Earnings Per Share (EPS) 4.88
    EBITDA 12.40
    Effective Tax Rate (%) 28.09
    Particulars DEC 2025 (Values in Cr)
    Revenue 21.11
    Operating Expense 17.77
    Net Profit 3.10
    Net Profit Margin (%) 14.68
    Earnings Per Share (EPS) 2.41
    EBITDA 7.39
    Effective Tax Rate (%) 22.36
    Particulars SEP 2025 (Values in Cr)
    Revenue 30.32
    Operating Expense 24.29
    Net Profit 4.96
    Net Profit Margin (%) 16.35
    Earnings Per Share (EPS) 3.86
    EBITDA 10.30
    Effective Tax Rate (%) 26.22
    Particulars JUN 2025 (Values in Cr)
    Revenue 24.67
    Operating Expense 20.73
    Net Profit 3.45
    Net Profit Margin (%) 13.98
    Earnings Per Share (EPS) 2.69
    EBITDA 7.95
    Effective Tax Rate (%) 25.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 24.43
    Operating Expense 17.94
    Net Profit 6.60
    Net Profit Margin (%) 27.01
    Earnings Per Share (EPS) 5.13
    EBITDA 12.15
    Effective Tax Rate (%) 24.82
    Particulars MAR 2026 (Values in Cr)
    Revenue 109.29
    Operating Expense 88.30
    Net Profit 17.77
    Net Profit Margin (%) 16.25
    Earnings Per Share (EPS) 13.84
    EBITDA 38.04
    Effective Tax Rate (%) 25.98
    Particulars MAR 2025 (Values in Cr)
    Revenue 108.60
    Operating Expense 81.03
    Net Profit 23.10
    Net Profit Margin (%) 21.27
    Earnings Per Share (EPS) 17.98
    EBITDA 42.95
    Effective Tax Rate (%) 26.19
    Particulars MAR 2024 (Values in Cr)
    Revenue 125.90
    Operating Expense 90.80
    Net Profit 28.12
    Net Profit Margin (%) 22.33
    Earnings Per Share (EPS) 22.35
    EBITDA 44.88
    Effective Tax Rate (%) 26.32
    Particulars MAR 2023 (Values in Cr)
    Revenue 91.36
    Operating Expense 71.84
    Net Profit 15.18
    Net Profit Margin (%) 16.61
    Earnings Per Share (EPS) 12.54
    EBITDA 24.15
    Effective Tax Rate (%) 24.95
    Particulars MAR 2022 (Values in Cr)
    Revenue 71.29
    Operating Expense 56.86
    Net Profit 13.40
    Net Profit Margin (%) 18.79
    Earnings Per Share (EPS) 11.16
    EBITDA 21.50
    Effective Tax Rate (%) 25.59
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 113.07
    ROE % 17.26
    ROCE % 19.47
    Total Debt to Total Equity 0.28
    EBITDA Margin 39.54
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 95.07
    ROE % 23.02
    ROCE % 24.40
    Total Debt to Total Equity 0.30
    EBITDA Margin 35.65
    Particulars MAR 2020 (Values in Cr)
    Book Value / Share 47.04
    ROE % 27.55
    ROCE % 34.65
    Total Debt to Total Equity 0.07
    EBITDA Margin 25.65
    Particulars MAR 2019 (Values in Cr)
    Book Value / Share 37.70
    ROE % 18.45
    ROCE % 25.54
    Total Debt to Total Equity 0.02
    EBITDA Margin 28.04
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 113.10
    ROE % 17.28
    ROCE % 19.47
    Total Debt to Total Equity 0.28
    EBITDA Margin 39.54
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 95.07
    ROE % 26.87
    ROCE % 27.76
    Total Debt to Total Equity 0.33
    EBITDA Margin 35.65
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 69.70
    ROE % 20.41
    ROCE % 22.40
    Total Debt to Total Equity 0.22
    EBITDA Margin 26.44
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 51.28
    ROE % 24.02
    ROCE % 32.38
    Total Debt to Total Equity 0.00
    EBITDA Margin 30.14
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 49.97
    ROE % 21.17
    ROCE % 27.42
    Total Debt to Total Equity 0.03
    EBITDA Margin 32.07
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 10.03
    Total Assets 191.94
    Total Liabilities 191.94
    Total Equity 145.15
    Share Outstanding 1
    Price to Book Ratio 6.29
    Return on Assets (%) 12.01
    Return on Capital (%) 12.58
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 16.26
    Total Assets 170.93
    Total Liabilities 170.93
    Total Equity 122.09
    Share Outstanding 1
    Price to Book Ratio 7.02
    Return on Assets (%) 16.44
    Return on Capital (%) 17.74
    Particulars MAR 2020 (Values in Cr)
    Cash & Short Term Investments 2.32
    Total Assets 55.27
    Total Liabilities 55.27
    Total Equity 42.24
    Share Outstanding 0
    Price to Book Ratio 1.55
    Return on Assets (%) 18.94
    Return on Capital (%) 22.51
    Particulars MAR 2019 (Values in Cr)
    Cash & Short Term Investments 0.99
    Total Assets 41.34
    Total Liabilities 41.34
    Total Equity 33.82
    Share Outstanding 0
    Price to Book Ratio 1.44
    Return on Assets (%) 15.08
    Return on Capital (%) 18.13
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 9.98
    Total Assets 191.97
    Total Liabilities 191.97
    Total Equity 145.19
    Share Outstanding 1
    Price to Book Ratio 6.29
    Return on Assets (%) 12.03
    Return on Capital (%) 12.59
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 16.18
    Total Assets 170.94
    Total Liabilities 170.94
    Total Equity 122.10
    Share Outstanding 1
    Price to Book Ratio 7.02
    Return on Assets (%) 16.44
    Return on Capital (%) 17.75
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 11.54
    Total Assets 137.97
    Total Liabilities 137.97
    Total Equity 87.19
    Share Outstanding 1
    Price to Book Ratio 3.58
    Return on Assets (%) 11.00
    Return on Capital (%) 12.63
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 3.88
    Total Assets 77.01
    Total Liabilities 77.01
    Total Equity 61.57
    Share Outstanding 1
    Price to Book Ratio 5.78
    Return on Assets (%) 17.39
    Return on Capital (%) 21.76
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 3.46
    Total Assets 60.59
    Total Liabilities 60.59
    Total Equity 50.00
    Share Outstanding 1
    Price to Book Ratio 6.70
    Return on Assets (%) 16.09
    Return on Capital (%) 19.44
    Particulars MAR 2025 (Values in Cr)
    Net Income 31.26
    Cash from Operations 40.71
    Cash from Investing -35.65
    Cash from Financing -1.08
    Net change in Cash -6.08
    Free Cash Flow 63.91
    Particulars MAR 2024 (Values in Cr)
    Net Income 38.16
    Cash from Operations 38.58
    Cash from Investing -33.00
    Cash from Financing 9.84
    Net change in Cash 7.28
    Free Cash Flow 69.72
    Particulars MAR 2020 (Values in Cr)
    Net Income 10.47
    Cash from Operations 4.58
    Cash from Investing -2.90
    Cash from Financing -0.47
    Net change in Cash 1.20
    Free Cash Flow 4.63
    Particulars MAR 2019 (Values in Cr)
    Net Income 6.23
    Cash from Operations -5.21
    Cash from Investing -0.07
    Cash from Financing -0.17
    Net change in Cash -5.46
    Free Cash Flow -5.11
    Particulars MAR 2025 (Values in Cr)
    Net Income 31.29
    Cash from Operations 40.71
    Cash from Investing -35.65
    Cash from Financing -1.05
    Net change in Cash -6.05
    Free Cash Flow 63.91
    Particulars MAR 2024 (Values in Cr)
    Net Income 38.17
    Cash from Operations 38.58
    Cash from Investing -33.09
    Cash from Financing 9.85
    Net change in Cash 7.20
    Free Cash Flow 69.72
    Particulars MAR 2023 (Values in Cr)
    Net Income 20.23
    Cash from Operations 17.09
    Cash from Investing -51.08
    Cash from Financing 38.65
    Net change in Cash 4.67
    Free Cash Flow 66.23
    Particulars MAR 2022 (Values in Cr)
    Net Income 18.00
    Cash from Operations 13.41
    Cash from Investing -11.91
    Cash from Financing -1.08
    Net change in Cash 0.41
    Free Cash Flow 28.74
    Particulars MAR 2021 (Values in Cr)
    Net Income 12.94
    Cash from Operations 3.31
    Cash from Investing -0.94
    Cash from Financing -0.65
    Net change in Cash 1.71
    Free Cash Flow 3.32
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 33.64 13.96 1.62 257.79 23.12 38.85
    BLISS GVS PHARMA LTD 454.10 36.50 4.03 4816.01 118.35 552.90
    CIPLA LTD. 1466.00 33.09 3.43 118430.12 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 465.55 21.78 3.36 1370.16 256.40 482.70
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 33.64 23.52 4.33 257.79 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 518.30 23.23 4.04 1498.44 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8090.05 105.72 23.17 20225.13 7630.00 9850.00
    BLISS GVS PHARMA LTD 454.10 49.09 4.16 4816.01 118.35 552.90

    Shree Ganesh Remedies Limited shareholding pattern

    Holding
    26.63%
    72.83%
    0.52%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Shree Ganesh Remedies Limited Technicals Summary

    631.75 -3.43 redarrow
    red-green-graph indicator
    11 Bearish
    5 Bullish
    • 5 Days 637.90
    • 26 Days 645.90
    • 10 Days 642.70
    • 50 Days 628.10
    • 12 Days 644.40
    • 100 Days 590.30
    • 20 Days 647.20
    • 200 Days 567.90
    641.75 PIVOT
    First Support 623.50 First Resistance 672.45 Second Support 592.80 Second Resistance 690.70 Third Support 574.55 Third Resistance 721.40
    RSI 51.97 ADX 10.58 MACD -1.55 Williams % R -45.80 Commodity Channel Index (CCI) -60.21
    Date 2026-07-30 Week 3009.00 Same Day 3440.00 Month 4605.00
    1 Year 0.48 3 Year 0.68
    Over 1 Month
    2.98% down
    Over 1 Year
    13.37% down
    Over 3 Months
    27.11% down
    Over 3 Years
    16.57% down
    Over 6 Months
    56.52% down
    Over 5 Years
    14.49% down

    Shree Ganesh Remedies Limited Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    07 Sep 2023 0.5 Final 07 Sep 2023 Equity shares
    15 Sep 2022 0.5 Final 16 Sep 2022 Equity shares
    08 Sep 2021 1.75 Final 11 Sep 2021 Equity shares
    01 Sep 2020 1.5 Final 02 Sep 2020 Equity shares
    22 Aug 2019 1.25 Final 24 Aug 2019 Equity shares
    19 Sep 2018 1.0 Final 22 Sep 2018 Equity shares
    Ex-Date Ex-Bonus Ratio
    02 Nov 2021 01 Nov 2021 1:5
    07 Oct 2020 06 Oct 2020 3:26

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Shree Ganesh Remedies Ltd?

    Answer Field

    Shree Ganesh Remedies Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 631.75 as on Jul 31 2026 03:29 PM.

    What is the Market Cap of Shree Ganesh Remedies Ltd Share?

    Answer Field

    The market cap of Shree Ganesh Remedies Ltd for NSE ₹ 0.00 & for BSE ₹ 811.00 as on Jul 31 2026 03:29 PM.

    What is the 52 Week High and Low of Shree Ganesh Remedies Ltd?

    Answer Field

    The 52 Week High and Low of Shree Ganesh Remedies Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 759.00 and ₹ 381.10.

    What is 1 year return for Shree Ganesh Remedies Ltd?

    Answer Field

    The 1 year returns on the stock has been 13.37%.

    What is the P/E Ratio of Shree Ganesh Remedies Ltd Share?

    Answer Field

    As on Jul 31 2026 03:29 PM the price-to-earnings (PE) ratio for Shree Ganesh Remedies Ltd share is 47.27.

    What is the PB ratio of Shree Ganesh Remedies Ltd Share?

    Answer Field

    As on Jul 31 2026 03:29 PM, the price-to-book (PB) ratio for Shree Ganesh Remedies Ltd share is 126.98.

    How to Buy Shree Ganesh Remedies Ltd Share?

    Answer Field

    You can trade in Shree Ganesh Remedies Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Shree Ganesh Remedies Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Shree Ganesh Remedies Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Shree Ganesh Remedies Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |